Indian Journal of Gastroenterology September-October 2020

[1] Patel RN(2020)An Indian national survey of therapeutic drug monitoring with anti-tumor necrosis (TNF) medications in inflammatory bowel disease Indian J Gastroenterol 39 176-185

[2] Nigam GB(2019)Developing a core outcome set for fistulising perianal Crohn's disease Gut. 68 226-238

[3] Jatale RG(2018)Oesophageal stenting: status quo and future challenges Br J Radiol 91 20170935-460

[4] Desai D(2018)EASL clinical practice guidelines for the management of patients with decompensated cirrhosis J Hepatol 69 406-1741

[5] Makharia G(2018)Metagenomics of pigmented and cholesterol gallstones: the putative role of bacteria Sci Rep 8 11218-50

[6] Ahuja V(2013)Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine Hepatology. 58 1732-769

[7] Limdi JK(2016)ACG clinical guideline: diagnosis and Management of Barrett's esophagus Am J Gastroenterol 111 30-1338

[8] Sahnan K(2020)AGA clinical practice update on endoscopic treatment of Barrett's esophagus with dysplasia and/or early cancer: expert review Gastroenterology. 158 760-284

[9] Tozer PJ(2015)Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target Am J Gastroenterol 110 1324-144

[10] Adegbola SO(2019)ECCO-ESGAR guideline for diagnostic assessment in IBD part 2: IBD scores and general principles and technical aspects J Crohns Colitis 13 273-undefined

[1] Patel RN(2020)An Indian national survey of therapeutic drug monitoring with anti-tumor necrosis (TNF) medications in inflammatory bowel disease Indian J Gastroenterol 39 176-185

[2] Nigam GB(2019)Developing a core outcome set for fistulising perianal Crohn's disease Gut. 68 226-238

[3] Jatale RG(2018)Oesophageal stenting: status quo and future challenges Br J Radiol 91 20170935-460

[4] Desai D(2018)EASL clinical practice guidelines for the management of patients with decompensated cirrhosis J Hepatol 69 406-1741

[5] Makharia G(2018)Metagenomics of pigmented and cholesterol gallstones: the putative role of bacteria Sci Rep 8 11218-50

[6] Ahuja V(2013)Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine Hepatology. 58 1732-769

[7] Limdi JK(2016)ACG clinical guideline: diagnosis and Management of Barrett's esophagus Am J Gastroenterol 111 30-1338

[8] Sahnan K(2020)AGA clinical practice update on endoscopic treatment of Barrett's esophagus with dysplasia and/or early cancer: expert review Gastroenterology. 158 760-284

[9] Tozer PJ(2015)Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target Am J Gastroenterol 110 1324-144

[10] Adegbola SO(2019)ECCO-ESGAR guideline for diagnostic assessment in IBD part 2: IBD scores and general principles and technical aspects J Crohns Colitis 13 273-undefined